Figure 6From: GPCR-like signaling mediated by smoothened contributes to acquired chemoresistance through activating GliJNK is involved in maintaining the chemoresistance of acquired chemoresistant cancer cells by activating Gli. The data are expressed as the means ± s.d. from three independent experiments. A, Treatment with the peptide JNK inhibitor JIP circumvents the chemoresistance of K562/A02 cells to Dox. K562/A02 cells were seeded into 96-well plates, and incubated with vehicle control or Dox supplemented with or without JIP (2 μM) for 72 h. B, K562/A02 cells were treated with JIP (2 μM) for 24 h, and were collected for QT-PCR analysis of the expression of Gli1. C, Ectopic expression of JNK dominant negative mutant plasmid JNK1(APF) by lenti-virus approach enhances the sensitivity of K562/A02 cells to Dox. K562/A02 cells with stable expressions of JNK1(APF) and GFP were seeded into 96-well plates, and incubated with vehicle control or Dox for 72 h. D, K562/A02 cells with stable expressions of JNK1(APF) and GFP were collected for QT-PCR analysis of expression of Gli1. E, Activation of JNK in K562 cells by JNK constitutive mutant plasmid MKK7-JNK1 causes insensitivity of K562 cells to Dox, while inhibition of Gli activity by GANT58 recovers the sensitivity of K562 cells to Dox. K562 cells with forced expression of MKK7-JNK1, MKK7-JNK1(APF), GFP by lenti-virus approach were seeded in 96-well plates, and incubated with vehicle control or Dox supplemented with or without various GANT58 (10 μM) for 72 h. F, K562 cells with forced expression of MKK7-JNK1, MKK7-JNK1(APF), GFP by lenti-virus approach were harvested for QT-PCR analysis of Gli1 expressions.Back to article page